Hu Lei
Impact in
- Dermatology top 2%
- Dermatology and Skin Diseases
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Ubiquitin and proteasome pathways 21
- Histone Deacetylase Inhibitors Research 10
- Protein Degradation and Inhibitors 7
- Natural product bioactivities and synthesis 4
- Retinoids in leukemia and cellular processes 4
- Immunology 14
- interferon and immune responses 6
- Co-authors
- Yingli Wu (37 shared papers)Hanzhang Xu (34 shared papers)Yuping Lai (4 shared papers)Dongqing Li (3 shared papers)Zhiheng Li (2 shared papers)Weiwei Wang (10 shared papers)Yelin Wu (3 shared papers)Hongquan Li (2 shared papers)
- Journals
- Cell Death and Disease (5 papers)PLoS ONE (5 papers)Cancer Letters (4 papers)Oncotarget (3 papers)Science China Life Sciences (3 papers)
- Partner nations
- ChinaThailandUnited States
In The Last Decade
Hu Lei
69 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Dermatology 177
- Immunology 340
- Cancer Research 187
- Rehabilitation 84
- Oncology 327
Countries citing papers authored by Hu Lei
This map shows the geographic impact of Hu Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Lei more than expected).
Fields of papers citing papers by Hu Lei
This network shows the impact of papers produced by Hu Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Lei. The network helps show where Hu Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Hu Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 199 | |
| 2 | 2016 | 89 | |
| 3 | 2013 | 84 | |
| 4 | 2012 | 72 | |
| 5 | 2016 | 59 | |
| 6 | 2014 | 59 | |
| 7 | 2018 | 47 | |
| 8 | 2016 | 46 | |
| 9 | 2017 | 40 | |
| 10 | 2015 | 35 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 31 | |
| 14 | 2015 | 31 | |
| 15 | 2020 | 30 | |
| 16 | 2021 | 29 | |
| 17 | 2021 | 28 | |
| 18 | 2015 | 27 | |
| 19 | 2019 | 26 | |
| 20 | 2021 | 26 |
About Hu Lei
Hu Lei is a scholar working on Molecular Biology, Immunology, Hematology, Cancer Research and Oncology, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (21 papers), Histone Deacetylase Inhibitors Research (10 papers), Protein Degradation and Inhibitors (7 papers), interferon and immune responses (6 papers), Multiple Myeloma Research and Treatments (5 papers), Genetics and Neurodevelopmental Disorders (5 papers), Natural product bioactivities and synthesis (4 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Dermatology (177 citations), Immunology (340 citations), Cancer Research (187 citations), Rehabilitation (84 citations) and Oncology (327 citations). Hu Lei has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Yingli Wu, Hanzhang Xu, Yuping Lai, Dongqing Li, Zhiheng Li, Weiwei Wang, Yelin Wu, Hongquan Li, Yue Wang and Tian Zhang. Their work appears in journals such as Cell Death and Disease, PLoS ONE, Cancer Letters, Oncotarget and Science China Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.